IL303497A - Cyclobenzaprine for the treatment of fibromyalgia - Google Patents

Cyclobenzaprine for the treatment of fibromyalgia

Info

Publication number
IL303497A
IL303497A IL303497A IL30349723A IL303497A IL 303497 A IL303497 A IL 303497A IL 303497 A IL303497 A IL 303497A IL 30349723 A IL30349723 A IL 30349723A IL 303497 A IL303497 A IL 303497A
Authority
IL
Israel
Prior art keywords
cyclobenzaprine hcl
mannitol
eutectic
composition
cyclobenzaprine
Prior art date
Application number
IL303497A
Other languages
English (en)
Hebrew (he)
Original Assignee
TONIX Pharmaceuticals Holding Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TONIX Pharmaceuticals Holding Corp filed Critical TONIX Pharmaceuticals Holding Corp
Publication of IL303497A publication Critical patent/IL303497A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL303497A 2020-12-07 2021-12-07 Cyclobenzaprine for the treatment of fibromyalgia IL303497A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063122469P 2020-12-07 2020-12-07
PCT/US2021/062244 WO2022125572A1 (en) 2020-12-07 2021-12-07 Cyclobenzaprine treatment for fibromyalgia

Publications (1)

Publication Number Publication Date
IL303497A true IL303497A (en) 2023-08-01

Family

ID=79686930

Family Applications (1)

Application Number Title Priority Date Filing Date
IL303497A IL303497A (en) 2020-12-07 2021-12-07 Cyclobenzaprine for the treatment of fibromyalgia

Country Status (9)

Country Link
US (2) US20240024256A1 (https=)
EP (1) EP4255407A1 (https=)
JP (1) JP2023554692A (https=)
CN (1) CN116940340A (https=)
AU (1) AU2021396509A1 (https=)
CA (1) CA3204202A1 (https=)
IL (1) IL303497A (https=)
MX (1) MX2023006720A (https=)
WO (1) WO2022125572A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3260042A1 (en) * 2022-06-21 2023-12-28 Tonix Pharmaceuticals Holding Corp. CYCLOBENZAPRINE TREATMENT FOR POST-ACUTE SEQUELAE OF A (SARS)-COV-2 (PASC) INFECTION
WO2025137348A1 (en) * 2023-12-19 2025-06-26 Tonix Pharmaceuticals Holding Corp. Cyclobenzaprine hcl for use in treating fibromyalgia with early onset response and favorable tolerability and side effect profile

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS63822B1 (sr) 2012-06-15 2023-01-31 Tonix Pharma Holdings Ltd Kompozicije i postupci za transmukoznu apsorpciju
SMT202400324T1 (it) 2013-03-15 2024-11-15 Tonix Pharma Ltd Formulazioni eutettiche di ciclobenzaprina cloridrato e mannitolo
MY186047A (en) * 2014-09-18 2021-06-17 Tonix Pharma Holdings Ltd Eutectic formulations of cyclobenzaprine hydrochloride
US20220117915A1 (en) * 2018-08-20 2022-04-21 Tonix Pharma Holdings Limited Methods of treating acute stress disorder and posttraumatic stress disorder

Also Published As

Publication number Publication date
AU2021396509A1 (en) 2023-06-29
WO2022125572A1 (en) 2022-06-16
CN116940340A (zh) 2023-10-24
EP4255407A1 (en) 2023-10-11
US20240024256A1 (en) 2024-01-25
JP2023554692A (ja) 2023-12-28
CA3204202A1 (en) 2022-06-16
MX2023006720A (es) 2023-08-18
US20260108477A1 (en) 2026-04-23
AU2021396509A9 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
US20260108477A1 (en) Cyclobenzaprine treatment for fibromyalgia
EP2135610A1 (en) Combination comprising DHODH inhibitors and methotrexate
EP3576738B1 (en) Gaboxadol monohydrate in the treatment of tinnitus
CA2259010A1 (en) Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter
Moore et al. Tramadol hydrochloride: analgesic efficacy compared with codeine, aspirin with codeine, and placebo after dental extraction
Brigham et al. Pharmacokinetic/pharmacodynamic correlation analysis of amantadine for levodopa-induced dyskinesia
TW201417807A (zh) 於一個體中改善甲狀腺功能之方法
Macleod et al. Paracetamol versus paracetamol‐codeine in the treatment of post‐operative dental pain: a randomized, double‐blind, prospective trial
TW202019400A (zh) 治療急性壓力症候群及創傷後壓力症候群之方法
AU2016303610A1 (en) Combination therapy using acamprosate and D-cycloserine
Richardson et al. Branched chain amino acid treatment of tardive dyskinesia in children and adolescents
US20210177805A1 (en) Use of gaboxadol in the treatment of gastrointestinal tract disorders and asthma
HK40102591A (zh) 纤维肌痛的环苯紮林治疗
US20250322926A1 (en) Early onset response, favorable tolerability, and side effect profile in the treatment of fibromyalgia
JP2025519847A (ja) （ＳＡＲＳ）－ＣｏＶ－２感染症の急性期後後遺症（ＰＡＳＣ）のためのシクロベンザプリン処置
KR102671524B1 (ko) 구역 반사의 치료를 위한 조성물 및 요법
KR20170040808A (ko) 다한증을 치료하는 방법
Hussar et al. New Drug Update 2020
Al-juma Comparison of the Onset of Diclofenac Potassium Sachet (Voltfast) and EntericCoated Diclofenac Potassium (Cataflam) in Treatment of Pain Following Tooth Extraction
Tetrud Balancing short-term symptom control and long-term functional outcomes in patients with Parkinson's disease
DAVIS et al. Pain and Comorbid Psychiatric Illnesses in Elderly People
JP2022541634A (ja) 疼痛に関連する睡眠障害を治療する方法
Approbal First human research protection awards given
Gorelick Treatment of Cocaine Addiction 23
Jason et al. Safety Evaluator: Amy Chen, PharmD